Form 4: ITRON SVP Sells Shares Under Pre-Arranged 10b5-1 Plan

ITRON SVP Donald L. Reeves III sold 526 shares of common stock for $96.64 per share under a pre-arranged Rule 10b5-1 trading plan.

Summary

• Donald L. Reeves III, Senior Vice President of Outcomes at ITRON, INC. (ITRI), reported the sale of common stock.
• The transactions occurred on December 10, 2025.
• A total of 526 shares of common stock were sold in two separate transactions (223 shares and 303 shares).
• Each share was sold at a price of $96.64.
• These sales were executed pursuant to a Rule 10b5-1 trading plan adopted by Mr. Reeves on September 11, 2025.
• Following these reported transactions, Mr. Reeves beneficially owns 18,542 shares of ITRON common stock.

Sentiment

Score: 5

Explanation: The filing reports a routine, pre-scheduled insider stock sale under a Rule 10b5-1 plan, which is a standard disclosure and generally considered neutral in sentiment as it does not necessarily reflect new information or a change in management's outlook.

Positives

• NA

Negatives

• The sale of 526 shares by a senior executive reduces their direct ownership stake in the company.

Risks

• Potential for minor negative investor sentiment due to insider selling, although mitigated by the pre-arranged nature of the Rule 10b5-1 plan.

Future Outlook

NA

Industry Context

NA

Comparison to Industry Standards

• NA

Related Party Transactions

• NA

Stakeholder Impact

• Shareholders may note the reduction in direct ownership by a senior executive, although the pre-arranged nature of the sale under a 10b5-1 plan typically mitigates concerns about its implications for company performance.

Next Steps

• NA

Key Dates

Recommendation

The filing details a routine, pre-scheduled insider stock sale under a Rule 10b5-1 plan. Such transactions are generally not indicative of new material information or a change in the company's fundamental outlook, thus not warranting a change in investment recommendation based solely on this disclosure.

Keywords

ITRON, ITRI, Form 4, insider trading, stock sale, Donald L. Reeves III, 10b5-1 plan, beneficial ownership